000 01648nam a2200409 i 4500
001 EBC3379436
003 MiAaPQ
005 20240123132511.0
006 m o d |
007 cr cnu||||||||
008 150425t20142014dcu o 000 0 eng d
020 _a9780309368407
_q(electronic bk.)
035 _a(MiAaPQ)EBC3379436
035 _a(Au-PeEL)EBL3379436
035 _a(CaPaEBR)ebr11042784
035 _a(OCoLC)923291273
040 _aMiAaPQ
_beng
_erda
_epn
_cMiAaPQ
_dMiAaPQ
050 4 _aT174.5
_b.I578 2014
082 0 _a363.1
_223
110 2 _aInstitute of Medicine (U.S.),
_eauthor.
245 1 0 _aCharacterizing uncertainty in the assessment of benefits and risks of pharmaceutical products :
_bworkshop in brief /
_cInstitute of Medicine (U.S.).
264 1 _a[Washington, District of Columbia] :
_bInstitute of Medicine of the National Academies,
_c2014.
264 4 _c2014
300 _a1 online resource (8 pages).
336 _atext
_2rdacontent
337 _acomputer
_2rdamedia
338 _aonline resource
_2rdacarrier
490 1 _aWorkshop in Brief
588 _aDescription based on online resource; title from PDF cover (ebrary, viewed April 25, 2015).
590 _aElectronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
650 0 _aRisk assessment
_vCongresses.
650 0 _aCommunication
_vCongresses.
655 4 _aElectronic books.
797 2 _aProQuest (Firm)
830 0 _aWorkshop in brief.
856 4 0 _uhttps://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=3379436
_zClick to View
999 _c207292
_d207292